Search or ask a question

Does low cholesterol affect fertility in women?

Lipid metabolism

Nuclear receptor

Liver X receptor

Coronary atherosclerosis

Best insight from top research papers

Low cholesterol levels may have an impact on fertility in women . Cholesterol plays a crucial role in female reproductive physiology, including ovarian steroid biosynthesis and uterine contractility . Genetic variations in cholesterol metabolic pathways, such as the low-density lipoprotein receptor (LDLR) and high-density lipoprotein receptor scavenger receptor class B type I (SR-BI), can affect human fertility . However, more research is needed to fully understand the relationship between low cholesterol and fertility in women.

Answers from top 5 papers

PDF

Open Access

More filters

Papers (5)	Insight
Open access•Journal Article Proximate determinants of fertility and reproductive health. Muhammad Farhanullah Khan, Amra Shirmeen - Show less +1 more 01 Jan 2007-Ulster Medical Journal 2 Citations	The provided paper does not mention anything about low cholesterol affecting fertility in women.
Open access•Journal Article•DOI Cholesterol lowering benefits women, too. TH Lee 01 Jan 1995-NEJM Journal Watch	The provided paper does not mention anything about the impact of low cholesterol on fertility in women.
Open access•Journal Article•DOI Genetic Alterations Affecting Cholesterol Metabolism and Human Fertility Anthony M. DeAngelis, Meaghan Roy-O'Reilly, Annabelle Rodriguez - Show less +2 more 01 Nov 2014-Biology of Reproduction 30 Citations	The paper does not directly address the question of whether low cholesterol affects fertility in women. The paper discusses the impact of genetic variations in cholesterol metabolic pathways on human fertility, but it does not specifically mention the effect of low cholesterol on fertility in women.
Journal Article•DOI Mice Prompt Look at Cholesterol's Role in Female Fertility Jennifer Couzin-Frankel 10 Jun 2011-Science 1 Citations	The paper does not provide a direct answer to the question of whether low cholesterol affects fertility in women. The paper discusses the role of cholesterol in female fertility but does not specifically address the impact of low cholesterol on fertility.
Open access•Journal Article•DOI Liver X Receptors and female reproduction: when cholesterol meets fertility! J. M. A. Lobaccaro, D. Gallot, S. Lumbroso, K. Mouzat - Show less +3 more 01 Jan 2013-Journal of Endocrinological Investigation 15 Citations	The paper does not directly address the question of whether low cholesterol affects fertility in women. The paper discusses the role of cholesterol in female reproductive physiology, but does not specifically mention the effects of low cholesterol on fertility.

My columns

Related Questions

What is the health impact of high cholesterol levels?5 answersHigh cholesterol levels have significant health implications. Elevated cholesterol can lead to immunological dysfunctions, increase the risk of atherosclerotic vascular disease, and impact disease progression, including cancer development and infectious diseases. In the context of COVID-19, high cholesterol levels in peripheral tissues, rather than the blood, can enhance the severity of the disease by facilitating viral entry and infectivity. Moreover, in prostate cancer, hypercholesterolemia is linked to increased tumor growth through intratumoral de novo steroidogenesis from cholesterol. These findings underscore the importance of managing cholesterol levels to mitigate various health risks, ranging from cardiovascular diseases to cancer progression and infectious diseases.

Does dietary cholesterol affect blood cholesterol levels?5 answersDietary cholesterol does have an effect on blood cholesterol levels, as supported by the evidence from epidemiological analysis, meta-analysis, and clinical trials. These studies have shown that there is a lack of correlation between dietary and blood cholesterol levels. Controlled metabolic studies have demonstrated that high-cholesterol intakes lead to moderate increases in serum cholesterol levels. Additionally, dietary cholesterol has been found to raise cholesterol levels in low-density lipoproteins (LDLs) and other lipoproteins, and population studies suggest that it is atherogenic beyond any rise in LDL concentrations. However, it is important to note that dietary cholesterol is just one of several dietary factors that influence serum cholesterol levels, including saturated fatty acids, trans fatty acids, soluble fiber, and total caloric intake. Therefore, to achieve substantial serum cholesterol lowering, favorable changes in all of these factors must be combined.

Does eating eggs increase cholesterol levels in the blood?4 answersEating eggs does not consistently increase cholesterol levels in the blood. Studies have shown that the impact of dietary cholesterol from eggs on blood cholesterol levels varies among individuals due to genetic factors. Epidemiological studies in both Japanese and Chinese populations have found no significant association between consuming one or two eggs per day and blood cholesterol levels or cardiovascular risk. However, a pooled analysis of six prospective cohorts from the USA found that higher consumption of dietary cholesterol or eggs was associated with an increased risk of cardiovascular disease and all-cause death. It is important to note that these findings are based on population-level data and individual responses to dietary cholesterol may vary. Therefore, it is recommended to monitor cholesterol levels and consider individual factors when determining egg consumption.

Is there a significant positive correlation between total cholesterol and iron levels in females?4 answersThere is evidence of a significant positive correlation between total cholesterol and iron levels in females. A study by He et al. found that serum iron level was positively correlated with high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC) in female students. Another study by Ma et al. also showed an inverse association between iron intake and the ratio of total cholesterol to HDL-C (TC/HDL-C) in healthy adults, with the effect being more pronounced in higher risk quantiles. These findings suggest that higher iron levels may be associated with higher total cholesterol levels in females. However, it is important to note that the exact mechanism and significance of this correlation are still not fully understood, and further research is needed to establish a definitive relationship between total cholesterol and iron levels in females.

What are the effects of Libido and fertility drink on lipid profile in men?5 answersLibido, a commercial product derived from fertilized chicken eggs, has been found to have a significant enhancing effect on sexual desire in men with normal and reduced sexual drive. It has been shown to improve sexual desire in as little as 2 weeks of use, with 58% of participants reporting improvement in low sexual desire. Additionally, Libido has been reported to have significant effects on the frequency of sexual intercourse, increased self-esteem, level of happiness, and stamina. However, there is no information available in the provided abstracts regarding the effects of Libido or a fertility drink on lipid profile in men.

What is the concentration of cholesterol in sterosomes?5 answersThe concentration of cholesterol in sterosomes is not explicitly mentioned in the abstracts provided.

See what other people are reading

What information does Clusterin give on altered kidney function?

Clusterin, a glycoprotein, plays a crucial role in kidney function. Studies show that Clusterin deficiency leads to renal lipid accumulation, mesangial expansion, fibrosis, and increased protein-to-creatinine ratio, indicating a link to chronic kidney disease. Additionally, Clusterin expression affects cell growth, migration, and survival in kidney cells under normoxic and hypoxic conditions, mainly through PI3K/AKT, PTEN, VEGF, and ERK/MAPK signaling pathways. Furthermore, Clusterin deficiency exacerbates renal inflammation, cellular infiltration, and tissue fibrosis post-ischemia-reperfusion injury, potentially mediated by pathways involving CCL12, Col3a1, MMP9, TIMP1, and EGF. Moreover, Clusterin suppresses macrophage infiltration, M1 polarization, and enhances phagocytic activity during kidney injury recovery, contributing to tissue repair. Overall, Clusterin provides valuable insights into the mechanisms underlying altered kidney function, renal injury, and chronic kidney disease progression.Do ERRα and NRF1 affect the gene GOT2?

The interaction between estrogen-related receptor alpha (ERRα) and nuclear respiratory factor 1 (NRF1) with the gene GOT2 (glutamic-oxaloacetic transaminase 2) is a complex interplay that influences various cellular processes, including metabolism and cancer progression. ERRα has been shown to regulate the transcription of SULT2A1, a gene involved in xenobiotic detoxification and hydroxysteroid homeostasis, by binding to specific promoter regions, suggesting that ERRα can directly influence gene expression through promoter interaction. Although this context does not directly mention GOT2, the mechanism of ERRα's action on gene regulation provides a basis for understanding its potential effects on GOT2. NRF1's role in recruiting the histone modifier LSD1 to transcriptional start sites (TSSs) of its target genes, including those involved in cell invasion and metabolism, indicates that NRF1 can significantly impact gene expression by modulating the chromatin state. This mechanism, while not directly linked to GOT2 in the provided contexts, underscores NRF1's capacity to influence gene expression broadly, including potentially GOT2. GOT2 plays a critical role in liver metabolism and cancer progression. It is downregulated in hepatocellular carcinoma (HCC) and associated with poor prognosis, indicating its importance in liver function and disease. The gene's involvement in metabolic reprogramming and its impact on cancer progression highlight the significance of understanding how transcription factors like ERRα and NRF1 might regulate its expression. While the direct interaction between ERRα/NRF1 and GOT2 is not explicitly detailed in the provided contexts, the mechanisms through which ERRα and NRF1 regulate gene expression suggest a potential for these transcription factors to affect GOT2. ERRα's ability to bind to gene promoters and NRF1's role in chromatin remodeling at TSSs provide a theoretical framework for their interaction with GOT2, especially considering GOT2's importance in metabolism and cancer. However, specific evidence directly linking ERRα and NRF1 to the regulation of GOT2 is not provided in the contexts, indicating a need for further research to elucidate these relationships.How does exercise influence collateral formation in the heart in diabetic patients?

Exercise plays a crucial role in influencing collateral formation in the heart of diabetic patients. Patients with type 2 diabetes mellitus (T2DM) often exhibit impaired coronary collateral vessel growth. Hyperglycemia, a common feature of diabetes, has been shown to attenuate collateral development. Additionally, diabetes has been identified as a negative predictor of collateral vessel formation, particularly due to impaired monocyte response to VEGF-A, a key factor in collateral vessel growth. Regular exercise can potentially counteract these negative effects by promoting arteriogenesis, the growth of preexisting arterioles into collateral vessels. By engaging in physical activity, diabetic patients may enhance collateral vessel formation, thereby improving myocardial perfusion and reducing the severity of myocardial damage and mortality after coronary artery occlusion.What is the role of neutrophil-monocyte aggregates?

Neutrophil-monocyte aggregates play a crucial role in various pathological conditions. These aggregates are influenced by inflammation and can contribute to exacerbating inflammatory responses in diseases like atherosclerosis and lupus. In atherosclerosis, monocyte-platelet aggregates are associated with disease progression, especially during acute events like myocardial infarction. In autoimmune diseases like lupus, neutrophils interact with immune complexes, leading to the activation of immune cells and tissue damage. Furthermore, neutrophils in Papillon-Lefevre syndrome lack the ability to form neutrophil extracellular traps (NETs) and associated aggregates, which results in nonresolving periodontitis due to the absence of a negative feedback mechanism for inflammation. Overall, neutrophil-monocyte aggregates are pivotal in linking inflammatory and immune responses in various diseases.What is the benefit of metformin for PCOS ?

Metformin, a widely used medication for managing Polycystic Ovary Syndrome (PCOS), offers a multifaceted range of benefits for women suffering from this condition. Primarily, metformin has been shown to significantly reduce body weight and Body Mass Index (BMI), which are crucial factors in managing PCOS symptoms and associated metabolic disorders. It also improves insulin sensitivity, a common issue in PCOS patients, thereby addressing one of the root causes of the syndrome. Furthermore, metformin has been associated with a reduction in fasting blood glucose levels and improvements in lipid profiles, including a decrease in low-density lipoprotein cholesterol (LDL-C), which are important for reducing the risk of cardiovascular diseases. Beyond metabolic improvements, metformin has demonstrated positive effects on reproductive health. It restores ovulation cycles and increases the clinical pregnancy rate in women with PCOS, thus addressing infertility issues that many patients face. Metformin treatment has also been linked to a reduction in miscarriage rates, further supporting its role in improving pregnancy outcomes. Additionally, it has a direct impact on reducing hyperandrogenism, a hallmark of PCOS, by lowering total testosterone and androstenedione levels. On a cellular level, metformin has been found to regulate the expression of genes and proteins related to ferroptosis and oxidative stress, suggesting a novel mechanism through which it improves PCOS conditions by affecting ovarian function and follicle development. It also modulates lipid metabolism, indicating its role in addressing dyslipidemia associated with PCOS. Moreover, metformin has shown potential in improving mental health outcomes, specifically reducing the odds of major depression among PCOS patients, which is significant given the higher prevalence of depression and anxiety in this population. In summary, metformin offers comprehensive benefits for managing PCOS, including metabolic improvements, enhanced reproductive health, and potential mental health benefits, making it a cornerstone in the treatment of PCOS.What is the role of cellular prion protein in PIP metabolism?

The cellular prion protein (PrPC) plays a crucial role in lipid metabolism and energetic regulation. PrPC contributes to the regulation of energetic metabolism by promoting mitochondrial oxidative degradation of glucose, limiting fatty acid oxidation, and preventing oxidative stress. Additionally, PrPC is involved in optimizing glutamate secretion, regulating Ca2+ entry, and protecting neurons from excitotoxicity. PrPC is also implicated in controlling Ca2+ homeostasis, potentially through the modulation of signaling pathways like p59Fyn- and p42/p44-ERK-dependent pathways. The multifaceted functions of PrPC, including its involvement in lipid metabolism, energetic regulation, and Ca2+ homeostasis, highlight its significance in cellular processes and neuroprotection.What is the role of cellular prion protein in phosphatidylinositol metabolism?

Cellular prion protein (PrPC) plays a significant role in lipid metabolism. It is a glycosylphosphatidylinositol-anchored protein primarily found in the plasma membrane, influencing various functions like neuroprotection and oxidative stress. PrPC's involvement in lipid metabolism is evident from studies showing excessive fat accumulation in the liver of PrPC knockout mice, along with altered expression of genes related to lipid metabolism. Additionally, over-expression of PrPC in hepatic cells led to a reduction in intracellular fat accumulation, further linking PrPC levels to lipid metabolism. Furthermore, PrPC has been associated with regulating glucose transporter 1 (Glut1) expression through the Fyn-HIF-2α pathway, impacting glycolysis and tumor growth in colorectal cancer cells.How do high levels of cortisol and adrenaline affect fetal development during pregnancy?

High levels of cortisol during pregnancy have been associated with adverse effects on fetal development. Research suggests that elevated maternal cortisol levels can lead to postpartum depressive symptoms, low birth weight, and lower weight for length/height z-score in infants. Additionally, cortisol exposure can impair trophoblast function and angiogenic pathways, affecting cell migration and tube-like structure formation. The equilibrium between cortisol and progesterone is crucial for maternal immune tolerance and pregnancy success; disruptions in this balance, such as increased cortisol due to stress, can lead to intrauterine inflammation and pregnancy complications. Furthermore, high maternal cortisol levels have been linked to shorter pregnancy duration and an increased risk of preterm delivery, particularly in women carrying male fetuses. These findings highlight the significant impact of elevated cortisol levels on fetal development and pregnancy outcomes.How do alterations in sphingolipid metabolism affect the diagnosis and treatment of colorectal cancer?

Alterations in sphingolipid metabolism play a crucial role in the diagnosis and treatment of colorectal cancer (CRC). Studies have shown that sphingolipids influence treatment response, aggressiveness, and prognosis in CRC patients. Aberrant sphingolipid metabolism is linked to the development and progression of CRC, affecting tumor biology, proliferation, migration, invasion, and apoptosis. Furthermore, sphingolipid profiles differ between healthy individuals and CRC patients, suggesting their potential as biomarkers for early detection and prediction of CRC. Understanding the molecular pathways involving sphingolipids is essential for tailoring treatment approaches, overcoming resistance, and improving clinical outcomes in CRC patients. Targeting sphingolipid metabolism may offer new avenues for personalized interventions and prognosis assessment in CRC.Can lipidomic profiling be used as a diagnostic tool for identifying early stages of neurodegenerative diseases?

Lipidomic profiling has emerged as a promising diagnostic tool for identifying early stages of neurodegenerative diseases like Alzheimer's disease (AD). Lipids play a crucial role in the pathophysiology of AD, with alterations in lipid metabolism being associated with disease progression. Studies have shown that specific lipid families, such as diglycerols, lysophosphatidylethanolamines, and sphingomyelins, exhibit significant differences in individuals with preclinical AD and mild cognitive impairment-AD compared to healthy controls, indicating their potential as biomarkers for early detection. Furthermore, blood lipid metabolites, including ceramides and polyunsaturated fatty acids, have shown impaired levels in early AD stages, suggesting their utility in minimally invasive and early clinical diagnosis of AD. Lipidomic profiling, therefore, holds promise as a valuable tool for the early identification of neurodegenerative diseases.How does the dominance of Bacteroides vulgatus affect the gut microbiome and overall health?

The dominance of Bacteroides vulgatus in the gut microbiome has significant implications for overall health. Research shows that B. vulgatus plays a crucial role in metabolic disorders, such as hyperlipidemia, by influencing bile acid metabolism, short-chain fatty acid biosynthesis, and serum metabolomic profiles. Additionally, B. vulgatus has been linked to beneficial effects in conditions like colitis, where its administration led to reduced inflammation, altered gut microbiota composition, and increased levels of short-chain fatty acids, contributing to an anti-inflammatory effect. Furthermore, the presence of B. vulgatus strains with specific antimicrobial proteins influences the selection of dominant fecal microbial strains, highlighting its stability and impact on the gut microbial community. Overall, the dominance of B. vulgatus can modulate the gut microbiome, influencing various health aspects from metabolic disorders to inflammatory conditions.